UPDATE: Prothena Receives FDA Fast Track Designation for NEOD001

By: via Benzinga
Prothena Corporation plc (Nasdaq: PRTA), a late-stage clinical biotechnology company focused on the discovery, development and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.